‘We’ve completed the engineering on the medicine’: Distributed Bio CEO on coronavirus cure

Distributed Bio CEO Jacob Glanville is actively working on a treatment for COVID-19. He joins Yahoo Finance’s On The Move panel to discuss how the antibodies their team acquired can be effective against the virus. …read more

Source:: Yahoo Finance


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.